期刊文献+

卡维地洛治疗老年高血压伴胰岛素抵抗的临床观察

暂未订购
导出
摘要 目的:观察卡维地洛对老年高血压伴胰岛素抵抗(IR)患者的治疗作用及机制。方法:将60例老年高血压伴IR的患者随机分为对照组及卡维地洛组,前者给予氨氯地平片,后者给予卡维地洛片。观察两组的临床疗效、治疗前、后进行口服葡萄糖耐量试验(OGTT)、胰岛素释放试验(IRT)及空腹血糖(FBG)、空腹胰岛素(FINS)、胰岛素敏感指数(ISI)及血清瘦素(LP)检测和动态血压监测,并进行统计学分析。结果:(1)两组空腹血糖(FBG)均有下降趋势,但用药前后对比差异无显著性(P>0.05)。(2)用药后卡维地洛组ISI有显著升高,与对照组相比差异有显著性(P<0.05),而对照组升高不显著(P>0.05)。(3)用药后卡维地洛组空腹胰岛素(FINS)及血清瘦素(LP)分别显著降低(P均<0.01)。(4)用药后卡维地洛组2h血糖及2h胰岛素均显著下降,与对照组相比差异有显著性(P<0.05)。结论:在高血压伴IR的患者中应用卡维地洛可明显改善IR,降低瘦素水平,可提高降压药物的疗效。
作者 郭秋慧 李婧
出处 《中国医院药学杂志》 CAS CSCD 北大核心 2006年第9期1125-1127,共3页 Chinese Journal of Hospital Pharmacy
基金 武汉市科委科技攻关项目(编号30220026)
  • 相关文献

参考文献14

  • 1李光伟.2型糖尿病系列讲座 第三讲:胰岛素敏感性评估及其在临床研究中的应用[J].中华内分泌代谢杂志,2000,16(3):198-200. 被引量:197
  • 2Reaven GM.Role of insulin resistance in human and disease[J].Diabetes,1988,37:1595-1599.
  • 3Reaven GM.Role of insulin resistance in human and compensatory hyperinsulinemia:role in hypertension,dyslipidemia,and coronary heart disease[J].Am Heart J,1991,121:1283-1289.
  • 4罗雪琚,杜传礼.Reaven's综合征[J].心血管病学进展,1993,14(1):11-13. 被引量:18
  • 5王秀问.X综合征[J].国外医学(老年医学分册),1994,15(1):19-22. 被引量:6
  • 6Suter PM,Locher R,Hasler E,et al.Is there a role for the ob gene product leptin in essential hypertension[J].Am J Hypertens,1998,11:1305-1311.
  • 7De Courten M,Zimmet P,Hodge A,et al.Hyperleptinmia:the missing link in the,metabolic syndrome[J].Diabet Med,1997,14:200-208.
  • 8Borntorp P.Metablic implications of body fat distribution[J].Diabetes Care,1991,14:1132-1143.
  • 9Chehab FF,Lim ME,Lu R.Correction of the sterility defect in homozygous obese female mice by treatment with the human recombinant leptin[J].Nat Genet,1996,12:318-320.
  • 10Timothy J T,Kieffer R S,Holler CA,et al.Leptin suppression of insulin secretion by the activation of ATP-sensitive K+channels in pancreatic beta-cells[J].Diabetes,1997,46:1087-1093.

二级参考文献13

  • 1Bristow MR.Mechanism of action of beta-blocking agents in heart failure[J].AM J Cardiol,1997,80(11A):26L-40L.
  • 2Yue TL,Cheng HY,Lysko PG,et al. Carvedilol,a new vasodilator and beta adrenoceptor antogonist,is an antioxidant and free radical scavenger[J].J Pharmacol Exp Ther,1992,263:92-98.
  • 3Packer M.β-adrenergic blockade in chronic heart failure:Principles,Progress,and Practice [J].Prog Cardiovasc Dis,1998, 41(1): 39-52.
  • 4Flesch M,Maack C,Cremer B et al.Effect of β-blockers on free radical-induced cardiac contraction dysfunction [J].Circulation, 1999,100(4):346-353.
  • 5Gilbert EM,Abraham WT,Olsen S,et al. Comparative hemodynamic,left ventricular functional and anti-adrenergic effects of chronic treatment with metoprolol versus carvedilol in the failing heart[J].Criculation,1996,94:2817-2828.
  • 6Feuerstein GI,Hamburger SA,Smith EF Ⅲ,et al.Myocardiol protection with carvedilol [J].J Cardiovasc Pharmacol,1992,19(suppl 1):S 138-141.
  • 7Feuerstein GI,Bril A,Ruffolo RR Jr.Protective effects of carvedilol in the myocardium[J].Am J Cardiol,1997,80(11 A):41-45.
  • 8Yue TL,M XL,Wang X,et al.Possible involvement of stress-actived protein kinase signaling pathway and fas receptor expression in prevention of ischemia/reperfusion-induced cardiomyocyte apoptosis by carvedilol[J].Cric Res,1998,82:166-174.
  • 9Feuerstein G,Yue TL,Ma XL,et al.Novel mechanisms in the treatment of heart failure:Inhibition of oxygen radicals and apoptosis by carvedilol[J]. Prog Cardiovasc Dis,1998,41(1):17-24.
  • 10Packer M,Bristow R,Cohn JN,et al.The effect of carvedilol on morbidity and mortality in patients with chronic heart failure[J].N Engl J Med,1996,334:1349-1355.

共引文献257

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部